Cochrane Summariesbeta

Independent high-quality evidence for health care decision making

Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease

Diana A, Sogos V, Bongioanni P, Miller RG, Moore DH
Published Online: 
January 21, 2009
This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective of the review will be to examine the efficacy of gabapentin and baclofen in delaying the progression of ALS.

Find the research